May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
ICG Enhanced-Transpupillary Thermotherapy for Choroidal Neovascularization in AMD
Author Affiliations & Notes
  • P.E. Liggett
    Ophthalmology, Cornell Univ/New York Hospital, New York, NY, United States
  • N. Chaudhry
    Ophthalmology, Yale University, New Haven, CT, United States
  • D. Tom
    Ophthalmology, Yale University, New Haven, CT, United States
  • H. Quiroz-Mercado
    Ophthalmology, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
  • D. Alfaro
    Ophthalmology, Charleston Retina Associates, Charleston, SC, United States
  • E. Jablon
    Ophthalmology, Charleston Retina Associates, Charleston, SC, United States
  • Footnotes
    Commercial Relationships  P.E. Liggett, None; N. Chaudhry, None; D. Tom, None; H. Quiroz-Mercado, None; D. Alfaro, None; E. Jablon, None.
  • Footnotes
    Support  New England Retina Research and Education Foundation
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1771. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      P.E. Liggett, N. Chaudhry, D. Tom, H. Quiroz-Mercado, D. Alfaro, E. Jablon; ICG Enhanced-Transpupillary Thermotherapy for Choroidal Neovascularization in AMD . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1771.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: A preliminary study to test the effectiveness of ICG-enhanced TTT for the treatment of choroidal neovascularization from AMD Methods: Retrospective interventional pilot study using ICG as a chromophore and TTT Results: Twelve patients with AMD and subfoveal CNV who were not eligible for PDT/vertiporforin were treated. Six patients remained stable in terms of visual acquity with resolution of the CNV over a period of 1 year. Three patients developed either a recurrent CNV or their CNV worsened form the treatment with further loss of vision. Three patients had resolution of the CNV and improved vision 1 -3 Snellen lines. Conclusions: This preliminary study suggests that ICG-enhanced TTT may offer a useful adjuvant treatment for subfoveal CNV related to AMD, especially in patients who are not candidates for PDT/vertiporforin. A further large randomized clinical trial is required to determine the future usefulness of this treatment modality

Keywords: age-related macular degeneration • photodynamic therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×